The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can ...
An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who ...
The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...
A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, ...
Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results